BG

Balu Gandhimathy

Director Director DIN 06753327
DIN 06753327 First appointment Dec 2013 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Dec 2013
Shareholding value Locked Premium profile

About Balu Gandhimathy

Balu Gandhimathy has 12 years in corporate governance. Formerly with 1 company, such as Nanoceut Therapeutics Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 06753327
Primary Designation Director
First Appointment 07 Dec 2013
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Managing Director 07 Dec 2013 2010 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Nanoceut Therapeutics Private Limited
Premium access

Shareholding and investment profile for Balu Gandhimathy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Balu Gandhimathy

Balu Gandhimathy has 12 years in corporate governance. Formerly with 1 company, such as Nanoceut Therapeutics Private Limited. Engaged in General Business. Contributes to corporate operations.

Balu Gandhimathy is associated with 0 companies as a director.

Balu Gandhimathy has expertise in General Business.

Balu Gandhimathy has 12 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available